CN114053355A - Traditional Chinese medicine composition for treating respiratory tract infection and preparation method and application thereof - Google Patents
Traditional Chinese medicine composition for treating respiratory tract infection and preparation method and application thereof Download PDFInfo
- Publication number
- CN114053355A CN114053355A CN202111572283.3A CN202111572283A CN114053355A CN 114053355 A CN114053355 A CN 114053355A CN 202111572283 A CN202111572283 A CN 202111572283A CN 114053355 A CN114053355 A CN 114053355A
- Authority
- CN
- China
- Prior art keywords
- parts
- respiratory tract
- tract infection
- traditional chinese
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating respiratory tract infection and a preparation method and application thereof, wherein the traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 150-300 parts of honeysuckle, 150-300 parts of green tea, 150-300 parts of lemon, 150-300 parts of momordica grosvenori, 100-150 parts of sophora flower, 100-150 parts of almond, 50-100 parts of wrinkled gianthyssop herb and 50-100 parts of mint; the traditional Chinese medicine composition can rapidly decompose sputum, ventilate lung, relieve asthma, kill bacteria and viruses, lead water, dissipate stagnation, dilate trachea, remove chest distress, supply oxygen to cells, relieve pain, and simultaneously when the lungs supply oxygen to cardiac veins, dark substances of biological medicines can rapidly enter blood circulation to supply oxygen to cell tissues of various organs, activate glands and improve immunity, thereby achieving the purposes of killing bacteria and viruses by fire, clearing phlegm and dampness, removing dirt and scale, and achieving the purposes of treating water and disease and preventing and treating respiratory tract infection.
Description
Technical Field
The invention relates to the technical field of compositions, in particular to a traditional Chinese medicine composition for treating respiratory tract infection and a preparation method and application thereof.
Background
Respiratory tract infection comprises upper respiratory tract infection, lower respiratory tract infection, bacterial pneumonia or mixed bacterial infection, the respiratory tract infection is the most common infectious disease, at present, medicaments such as quinolone antibiotics and cephalosporin antibiotics are mainly used for treating the respiratory tract infection at home and abroad, and in order to control the state of illness, the dosage is often large, so that the drug resistance of bacteria is enhanced; in addition, antibiotics bring certain side effects to the body; therefore, antibiotics have not been able to meet the demand for drugs for the prevention and treatment of respiratory infections.
Therefore, there is a need to develop a safe drug capable of preventing and treating respiratory tract infection.
Disclosure of Invention
The invention aims to provide a traditional Chinese medicine composition for treating respiratory tract infection and a preparation method and application thereof.
In order to achieve the above purpose of the present invention, the following technical solutions are adopted:
the invention provides a traditional Chinese medicine composition for treating respiratory tract infection, which is prepared from the following raw materials in parts by weight:
150-300 parts of honeysuckle, 150-300 parts of green tea, 150-300 parts of lemon, 150-300 parts of momordica grosvenori, 100-150 parts of sophora flower, 100-150 parts of almond, 50-100 parts of wrinkled gianthyssop herb and 50-100 parts of mint.
Preferably, the traditional Chinese medicine composition for treating respiratory tract infection is prepared from the following raw materials in parts by weight:
200-250 parts of honeysuckle, 200-250 parts of green tea, 200-250 parts of lemon, 200-250 parts of momordica grosvenori, 120-130 parts of sophora flower, 120-130 parts of almond, 60-80 parts of wrinkled gianthyssop herb and 60-80 parts of mint.
Preferably, the traditional Chinese medicine composition for treating respiratory tract infection is prepared from the following raw materials in parts by weight:
220 parts of honeysuckle, 230 parts of green tea, 220 parts of lemon, 240 parts of momordica grosvenori, 120 parts of sophora flower, 130 parts of almond, 70 parts of wrinkled gianthyssop herb and 70 parts of mint.
The second aspect of the present invention provides a preparation method of the above traditional Chinese medicine composition for treating respiratory tract infection, which comprises the following steps:
(a) weighing the raw materials in parts by weight;
(b) soaking the raw materials in ethanol, and distilling to obtain extracts;
(c) mixing the extracts of the raw materials to obtain the traditional Chinese medicine composition for treating respiratory tract infection.
Preferably, the mass volume ratio of the raw materials to the ethanol is 1: 3-10.
Preferably, the soaking temperature is room temperature, and the soaking time is 5-10 h
Preferably, the step (a) further comprises pulverizing each raw material to a particle size of not more than 2mm, respectively.
In a third aspect of the present invention, there is provided a pharmaceutical granule for treating upper respiratory tract infection, wherein the pharmaceutical granule comprises the above-mentioned Chinese medicinal composition.
Preferably, the medicine granule for treating respiratory tract infection is prepared by mixing and granulating the traditional Chinese medicine composition with biological enzyme;
the mass content of the biological enzyme in the medicine particles is 4-9%. The biological enzyme can be obtained commercially.
Preferably, each granule of the medicine granule for treating respiratory tract infection weighs 0.2-0.3 g.
Compared with the prior art, the invention has the beneficial effects that at least:
the traditional Chinese medicine composition can rapidly decompose sputum, ventilate lung, relieve asthma, kill bacteria and viruses, lead water, dissipate stagnation, dilate trachea, remove chest distress, supply oxygen to cells, relieve pain, and simultaneously when the lungs supply oxygen to cardiac veins, dark substances of biological medicines can rapidly enter blood circulation to supply oxygen to cell tissues of various organs, activate glands and improve immunity, thereby achieving the purposes of killing bacteria and viruses by fire, clearing phlegm and dampness, removing dirt and scale, and achieving the purposes of treating water and disease and preventing and treating respiratory tract infection.
The medicine granule has the effects of quickly relieving or eliminating common upper respiratory tract infection and bacterial virus infection, particularly inflammatory swelling and pain of nose, pharynx, throat and oral cavity, fever, cough and sputum of trachea, lung and the like, asthma, chest distress or acute and chronic infectious diseases accompanied with insufficient oxygen supply of heart and brain and the like in a mist-sucking administration mode.
The raw material components of the invention are medicinal and edible traditional Chinese medicine extracts, so the invention has no side effect and is safe and effective in clinical use.
Detailed Description
The following describes embodiments of the present invention in detail with reference to the following embodiments. The following examples are only for illustrating the technical solutions of the present invention more clearly, and therefore are only examples, and the protection scope of the present invention is not limited thereby.
It is to be noted that, unless otherwise specified, technical or scientific terms used herein shall have the ordinary meaning as understood by those skilled in the art to which the invention pertains.
Example 1
Traditional Chinese medicine composition for treating respiratory tract infection
The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight:
300 parts of honeysuckle, 150 parts of green tea, 150 parts of lemon, 300 parts of momordica grosvenori, 150 parts of sophora flower, 100 parts of almond, 100 parts of wrinkled gianthyssop and 50 parts of mint.
Second, preparation method
The preparation method of the traditional Chinese medicine composition for treating respiratory tract infection comprises the following steps:
(a) weighing the raw materials according to the weight parts, and respectively crushing the raw materials to obtain particles with the particle size of not more than 2 mm;
(b) respectively soaking the raw materials in ethanol at room temperature for 7h according to the mass-to-volume ratio of 1: 8, and distilling to obtain extracts of the raw materials;
(c) mixing the extracts of the above materials to obtain the Chinese medicinal composition for treating respiratory tract infection.
Example 2
Traditional Chinese medicine composition for treating respiratory tract infection
The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight:
150 parts of honeysuckle, 300 parts of green tea, 300 parts of lemon, 150 parts of momordica grosvenori, 100 parts of sophora flower, 150 parts of almond, 50 parts of wrinkled gianthyssop and 100 parts of mint.
Second, preparation method
The preparation method of the traditional Chinese medicine composition for treating respiratory tract infection comprises the following steps:
(a) weighing the raw materials according to the weight parts, and respectively crushing the raw materials to obtain particles with the particle size of not more than 2 mm;
(b) respectively soaking the raw materials in ethanol at room temperature for 7h according to the mass-to-volume ratio of 1: 5, and distilling to obtain extracts of the raw materials;
(c) mixing the extracts of the above materials to obtain the Chinese medicinal composition for treating respiratory tract infection.
Example 3
Traditional Chinese medicine composition for treating respiratory tract infection
The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight:
250 parts of honeysuckle, 200 parts of green tea, 250 parts of lemon, 250 parts of momordica grosvenori, 120 parts of sophora flower, 120 parts of almond, 80 parts of wrinkled gianthyssop and 60 parts of mint.
Second, preparation method
The preparation method of the traditional Chinese medicine composition for treating respiratory tract infection comprises the following steps:
(a) weighing the raw materials according to the weight parts, and respectively crushing the raw materials to obtain particles with the particle size of not more than 2 mm;
(b) respectively soaking the raw materials in ethanol at room temperature for 10h according to the mass-to-volume ratio of 1: 3, and distilling to obtain extracts of the raw materials;
(c) mixing the extracts of the above materials to obtain the Chinese medicinal composition for treating respiratory tract infection.
Example 4
Traditional Chinese medicine composition for treating respiratory tract infection
The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight:
200 parts of honeysuckle, 250 parts of green tea, 200 parts of lemon, 200 parts of momordica grosvenori, 130 parts of sophora flower, 130 parts of almond, 60 parts of wrinkled gianthyssop and 80 parts of mint.
Second, preparation method
The preparation method of the traditional Chinese medicine composition for treating respiratory tract infection comprises the following steps:
(a) weighing the raw materials according to the weight parts, and respectively crushing the raw materials to obtain particles with the particle size of not more than 2 mm;
(b) respectively soaking the raw materials in ethanol at room temperature for 5h according to the mass-to-volume ratio of 1: 10, and distilling to obtain extracts of the raw materials;
(c) mixing the extracts of the above materials to obtain the Chinese medicinal composition for treating respiratory tract infection.
Example 5
Traditional Chinese medicine composition for treating respiratory tract infection
The traditional Chinese medicine composition is prepared from the following raw materials in parts by weight:
220 parts of honeysuckle, 230 parts of green tea, 220 parts of lemon, 240 parts of momordica grosvenori, 120 parts of sophora flower, 130 parts of almond, 70 parts of wrinkled gianthyssop herb and 70 parts of mint.
Second, preparation method
The preparation method of the traditional Chinese medicine composition for treating respiratory tract infection comprises the following steps:
(a) weighing the raw materials according to the weight parts, and respectively crushing the raw materials to obtain particles with the particle size of not more than 2 mm;
(b) respectively soaking the raw materials in ethanol at room temperature for 8h according to the mass-to-volume ratio of 1: 6, and distilling to obtain extracts of the raw materials;
(c) mixing the extracts of the above materials to obtain the Chinese medicinal composition for treating respiratory tract infection.
Example 6
The embodiment is a drug granule for treating upper respiratory tract infection, which comprises the traditional Chinese medicine composition in the embodiment 1 and biological enzyme, wherein the mass content of the biological enzyme in the drug granule is 5%;
the medicine granules are prepared by mixing and granulating the traditional Chinese medicine composition in the embodiment 1 with biological enzyme, wherein each granule is 0.25g in weight.
Example 7
The embodiment is a drug granule for treating upper respiratory tract infection, which comprises the traditional Chinese medicine composition in the embodiment 3 and biological enzyme, wherein the mass content of the biological enzyme in the drug granule is 4%;
the medicine granules are prepared by mixing and granulating the traditional Chinese medicine composition in the embodiment 3 with biological enzyme, wherein each granule is 0.3g in weight.
Example 8
The embodiment is a drug granule for treating upper respiratory tract infection, which comprises the traditional Chinese medicine composition in the embodiment 4 and biological enzyme, wherein the mass content of the biological enzyme in the drug granule is 9%;
the medicine granules are prepared by mixing and granulating the traditional Chinese medicine composition in the embodiment 4 with biological enzyme, wherein each granule is 0.2g in weight.
Example 9
The embodiment is a drug granule for treating upper respiratory tract infection, which comprises the traditional Chinese medicine composition in the embodiment 5 and biological enzyme, wherein the mass content of the biological enzyme in the drug granule is 7%;
the medicine granules are prepared by mixing and granulating the traditional Chinese medicine composition in the embodiment 5 with biological enzyme, wherein each granule is 0.25g in weight.
The taking method (mist absorption method) and the action mechanism of the medicine particles are as follows:
the medicine particles are heated by the heating rod, a user directly sucks the heated and volatilized medicine into the oral cavity to enter waste, hot air with higher relative heat degree is utilized to directly contact with mucosal tissue to generate heat flow to accelerate and impact a focus, so that the relatively low-temperature phlegm-damp liquid and the entering hot air generate hot and cold air convection collision to generate resonance, the sputum is rapidly decomposed, respective pharmacological functions are rapidly exerted, and the purpose of preventing and treating respiratory tract infection is achieved.
Typical cases are as follows:
case 1
In plum, male, 30 years old, 20 months at 2021, throat swelling and pain due to cold, fever, tonsil inflammation and swelling, nasal obstruction and discharge, paroxysmal cough with thick yellow sputum can only be eaten after flowing juice. The recurrence of throat tonsillitis and upper respiratory tract infection are diagnosed in a hospital, and the conventional antibiotics, antiviral and other Chinese and western patent medicines are given, after taking for one week, only fever is relieved, the symptoms are slightly relieved, but the existing stomachache and vomiting, inappetence and anxiety are caused, and the medicines are stopped taking; 3 months and 30 days, the medicine particles prepared in the embodiment 9 of the invention are taken, wherein the taking method is a heating and mist sucking method, and the medicine particles are sucked for 3 times every day and 2g each time; in the evening, cough stops, pain in the oral cavity is greatly reduced, and after 3 days of continuous fog inhalation, the symptoms are completely clear.
Case 2
The medicine is used for treating certain von, female, 42 years old, self-complaint, self-help, children suffering from chronic pharyngolaryngitis, long-term treatment without cure, susceptibility to common cold and relapse, pharyngalgia and hoarseness, itching and dry cough of throat, sleeping difficulty at night, emaciation of weak people, chronic pharyngolaryngitis diagnosed by a plurality of large hospitals, lymphofollicular tissue hyperplasia, and the traditional Chinese medicine and the western medicine have no symptoms which can be cured and can only be used for maintaining the common cold with less incidence; the medicine particles prepared in the embodiment 9 of the invention are used from the end of 2020, all other medicines are stopped taking, the patient specially goes to a hospital in 10 months in 2021 and is subjected to laryngoscopy, the lymphoid follicle tissue of the throat is normal, the original symptoms disappear, and the patient is fat by 10 jin.
Case 3
Sunzhi, a female, is 68 years old, and Henan is a horse shop, and the female is suffered from chronic bronchitis, even more, cough and excessive phlegm at night can not fall asleep, and ephedrine and aminophylline need to be taken for a long time; when the medicine granules prepared in the embodiment 9 of the invention are used from 11 months in 2018, all the medicines for expanding the trachea and reducing phlegm are stopped taking in winter in the same year, the cough is reduced, almost no phlegm exists, the disease is not attacked in winter until all the people are normal in the year, and the medicines are not used at ordinary times.
Case 4
Zhangqi, male, 46 years old, Anhui, and Hostan, suffering from rhinitis and bullous lung, often suffering from chest distress and short breath for many years, dyspnea due to physical movement, and cough and excessive phlegm with difficulty in healing after catching a cold; after the medicine particles prepared in the embodiment 9 of the invention are taken for 20 days, the symptoms disappear, and at present, the medicine particles are taken all the time without relapse.
Finally, it should be noted that: the above embodiments are only used to illustrate the technical solution of the present invention, and not to limit the same; while the invention has been described in detail and with reference to the foregoing embodiments, it will be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; such modifications and substitutions do not depart from the spirit and scope of the present invention, and they should be construed as being included in the following claims and description.
Claims (10)
1. A traditional Chinese medicine composition for treating respiratory tract infection is characterized by being prepared from the following raw materials in parts by weight:
150-300 parts of honeysuckle, 150-300 parts of green tea, 150-300 parts of lemon, 150-300 parts of momordica grosvenori, 100-150 parts of sophora flower, 100-150 parts of almond, 50-100 parts of wrinkled gianthyssop herb and 50-100 parts of mint.
2. The traditional Chinese medicine composition for treating respiratory tract infection according to claim 1, which is prepared from the following raw materials in parts by weight:
200-250 parts of honeysuckle, 200-250 parts of green tea, 200-250 parts of lemon, 200-250 parts of momordica grosvenori, 120-130 parts of sophora flower, 120-130 parts of almond, 60-80 parts of wrinkled gianthyssop herb and 60-80 parts of mint.
3. The traditional Chinese medicine composition for treating respiratory tract infection according to claim 1, which is prepared from the following raw materials in parts by weight:
220 parts of honeysuckle, 230 parts of green tea, 220 parts of lemon, 240 parts of momordica grosvenori, 120 parts of sophora flower, 130 parts of almond, 70 parts of wrinkled gianthyssop herb and 70 parts of mint.
4. The method for preparing a Chinese medicinal composition for treating respiratory tract infection according to any one of claims 1 to 3, which comprises the following steps:
(a) weighing the raw materials in parts by weight;
(b) soaking the raw materials in ethanol, and distilling to obtain extracts;
(c) mixing the extracts of the raw materials to obtain the traditional Chinese medicine composition for treating respiratory tract infection.
5. The preparation method according to claim 4, wherein the mass-volume ratio of each raw material to ethanol is 1: 3-10.
6. The preparation method according to claim 4, wherein the soaking temperature is room temperature and the soaking time is 5-10 hours.
7. The method of claim 4, wherein the step (a) further comprises pulverizing each raw material to a particle size of not more than 2mm, respectively.
8. A pharmaceutical granule for treating upper respiratory tract infection, which comprises the Chinese medicinal composition of any one of claims 1 to 7.
9. The pharmaceutical granule for treating respiratory tract infection according to claim 8, which is prepared by mixing and granulating the traditional Chinese medicine composition of any one of claims 1 to 7 with biological enzyme;
the mass content of the biological enzyme in the medicine particles is 4-9%.
10. The drug particles for treating respiratory tract infection according to claim 8, wherein each drug particle for treating respiratory tract infection is 0.2-0.3 g in weight.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111572283.3A CN114053355A (en) | 2021-12-21 | 2021-12-21 | Traditional Chinese medicine composition for treating respiratory tract infection and preparation method and application thereof |
| NL2033681A NL2033681A (en) | 2021-12-21 | 2022-12-07 | Traditional chinese medicine composition for treating respiratory tract infection and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111572283.3A CN114053355A (en) | 2021-12-21 | 2021-12-21 | Traditional Chinese medicine composition for treating respiratory tract infection and preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114053355A true CN114053355A (en) | 2022-02-18 |
Family
ID=80230097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111572283.3A Pending CN114053355A (en) | 2021-12-21 | 2021-12-21 | Traditional Chinese medicine composition for treating respiratory tract infection and preparation method and application thereof |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN114053355A (en) |
| NL (1) | NL2033681A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111228426A (en) * | 2020-04-19 | 2020-06-05 | 湖北清大中药饮片有限公司 | A Chinese medicinal granule used as both medicine and food for treating infantile upper respiratory infection |
| CN111407817A (en) * | 2020-05-18 | 2020-07-14 | 赖宇 | Traditional Chinese medicine composition for preventing respiratory tract infection pathogenic microorganisms and preparation method thereof |
-
2021
- 2021-12-21 CN CN202111572283.3A patent/CN114053355A/en active Pending
-
2022
- 2022-12-07 NL NL2033681A patent/NL2033681A/en unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111228426A (en) * | 2020-04-19 | 2020-06-05 | 湖北清大中药饮片有限公司 | A Chinese medicinal granule used as both medicine and food for treating infantile upper respiratory infection |
| CN111407817A (en) * | 2020-05-18 | 2020-07-14 | 赖宇 | Traditional Chinese medicine composition for preventing respiratory tract infection pathogenic microorganisms and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 荀红军等: "连花清瘟胶囊治疗病毒性感冒的疗效观察", 《中国医药指南》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| NL2033681A (en) | 2023-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102940832B (en) | Medicament for treating chronic bronchitis and preparation method thereof | |
| CN101491585B (en) | Traditional Chinese medicine composite with throat-clearing function and preparation method thereof | |
| CN103127369A (en) | Traditional Chinese medicine composition for treating respiratory tract haze disoperation and preparation method | |
| CN102166280B (en) | Chinese medicinal composition for preventing and treating common cold and influenza and preparation method thereof | |
| CN118021929A (en) | Pharmaceutical composition for treating cough and preparation method thereof | |
| CN104352587A (en) | Ointment for treating rhinitis | |
| CN104642698A (en) | Candy capable of clearing heat, relieving sore-throat and detoxifying | |
| CN105998599A (en) | Traditional Chinese medicine composition for treating viral respiratory tract infection and preparation method thereof | |
| CN103623267B (en) | Medication for treating allergic rhinitis | |
| CN105688157A (en) | Traditional Chinese medicine compound preparation for resisting swine influenza virus and preparing method thereof | |
| CN116139237B (en) | A Chinese medicinal composition for preventing and treating respiratory tract infection caused by coronavirus, and its application | |
| CN103494927A (en) | Traditional Chinese medicine composition for treating chicken respiratory disease and preparation method thereof | |
| CN114053355A (en) | Traditional Chinese medicine composition for treating respiratory tract infection and preparation method and application thereof | |
| CN104800655A (en) | Traditional Chinese medicine for treating infantile pneumonia | |
| CN114099584B (en) | Antiviral and antibacterial traditional Chinese medicine composition containing houttuynia cordata, and preparation method and application thereof | |
| CN106620205A (en) | Externally-used traditional Chinese medicine for foot bath to treat pediatric fever | |
| CN116585370B (en) | Traditional Chinese medicine composition and application thereof in preparation of medicine for treating/preventing acute upper respiratory tract infection | |
| CN101259211A (en) | Medicaments assembly for treating acute or chronic pharyngitis and preparation thereof | |
| CN101797372B (en) | Fire-friend cold capsule | |
| CN1193777C (en) | Chinese medicine for curing cold by omphalotherapy and its preparing process | |
| CN105343485A (en) | Medicine composition for treating nasosinusitis and application thereof | |
| CN111110767A (en) | Medicine for treating infantile pneumonia | |
| CN112691169A (en) | Medicine for treating rhinopathy | |
| CN111714552A (en) | Traditional Chinese medicine formula for inactivating virus and blocking infection vaporization therapy | |
| CN103623389A (en) | Traditional Chinese medicinal composition for treating wind-cold type pediatric bronchitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |